United States Biotechnology & Medical Research

Surface Oncology Inc (SURF)

Track

Track

Ticker: SURF Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Surface Oncology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
ROSS ROBERT W. Chief Executive Officer Officer
Transaction date
Sale
Price
486.78
Quantity 37,721 -30.4%
Value US$4,655,205
Adams Chandra Deputy GC Officer
Transaction date
Sale
Price
95.06
Quantity 1,586 -27.5%
Value US$1,395,353
ONEILL ALISON Chief Medical Officer Officer
Transaction date
Sale
Price
413.46
Quantity 41,295 +18.2%
Value US$1,973,319
FEES JESSICA Chief Financial Officer Officer
Transaction date
Sale
Price
0.94
Quantity 9,434 -8.5%
Value US$8,868
Palombella Vito J. Chief Scientific Officer Officer
Transaction date
Sale
Price
1.72
Quantity 4,463 -4.9%
Value US$7,676
FEES JESSICA Chief Financial Officer Officer
Transaction date
Sale
Price
1.72
Quantity 5,980 -5.1%
Value US$10,286
ONEILL ALISON Chief Medical Officer Officer
Transaction date
Sale
Price
1.72
Quantity 4,463 -6.5%
Value US$7,676
ROSS ROBERT W. Chief Executive Officer Officer
Transaction date
Sale
Price
1.72
Quantity 10,594 -9.6%
Value US$18,222
RATH HENRY C. Chief Business Officer Officer
Transaction date
Sale
Price
1.72
Quantity 5,676 -14.9%
Value US$9,763
ONEILL ALISON Chief Medical Officer Officer
Transaction date
Sale
Price
6.10
Quantity 14,809 -32.9%
Value US$90,335
Palombella Vito J. Chief Scientific Officer Officer
Transaction date
Sale
Price
6.10
Quantity 26,325 -32.9%
Value US$160,582
ROSS ROBERT W. Chief Executive Officer Officer
Transaction date
Sale
Price
6.10
Quantity 33,500 -38.1%
Value US$204,350
3.0
Goater Jeff Non-Executive Director
Transaction date
Sale
Price
6.10
Quantity 127,778 -49.7%
Value US$779,446
FEES JESSICA Chief Financial Officer Officer
Transaction date
Sale
Price
6.10
Quantity 19,854 -20.0%
Value US$121,109
Nogelo Liisa I Chief Legal Officer Officer
Transaction date
Sale
Price
6.10
Quantity 26,325 -32.9%
Value US$160,582
3.0
Goater Jeff Non-Executive Director
Transaction date
Sale
Price
7.61
Quantity 15,273 -5.6%
Value US$116,226
3.0
Goater Jeff Non-Executive Director
Transaction date
Sale
Price
7.66
Quantity 234,727 -47.3%
Value US$1,798,619
ROSS ROBERT W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.35
Quantity 1,000 -1.1%
Value US$11,350
3.0
Goater Jeff Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
12.50
Quantity 2,500 -0.9%
Value US$31,250
FEES JESSICA See Remarks Officer
Transaction date
Planned sale
Price
12.45
Quantity 1,500 -1.5%
Value US$18,675
3.0
Goater Jeff Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
10.69
Quantity 2,500 -0.9%
Value US$26,718
FEES JESSICA See Remarks Officer
Transaction date
Planned sale
Price
11.19
Quantity 1,500 -1.5%
Value US$16,785
3.0
Goater Jeff Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
13.00
Quantity 5,000 -1.9%
Value US$65,000
ROSS ROBERT W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
12.25
Quantity 2,000 -2.2%
Value US$24,500
ROSS ROBERT W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.95
Quantity 7,000 -7.1%
Value US$83,650
3.4
GRAYZEL DAVID S. Non-Executive Director
Transaction date
Sale
Price
18.10
Quantity 1,700,000 -36.6%
Value US$30,770,000
ROSS ROBERT W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.48
Quantity 1,000 -1.0%
Value US$10,480
ROSS ROBERT W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.05
Quantity 1,405 -1.4%
Value US$14,120
ROSS ROBERT W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.05
Quantity 595 -0.6%
Value US$5,980
ROSS ROBERT W. Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.05
Quantity 4,000 -3.8%
Value US$40,200
3.1
EcoR1 Capital, LLC Large shareholder
Transaction date
Sale
Price
7.14
Quantity 332,780 -6.6%
Value US$2,376,681
3.0
Goater Jeff Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.23
Quantity 5,000 +1.9%
Value US$16,150
Atlas Venture Fund IX, L.P. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 100,000 +2.2%
Value US$1,500,000
Viswanathan Ravi Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
Sonsini Peter W. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
Florence Anthony A. Jr. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
GRAYZEL DAVID S. Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 100,000 +2.2%
Value US$1,500,000
New Enterprise Associates 14, L.P. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
LV Management Group, LLC Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 266,000 +8.4%
Value US$3,990,000
Shanafelt Armen Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 266,000 +8.4%
Value US$3,990,000
BARRIS PETER J Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
BARRETT M JAMES Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
Novartis Institutes for BioMedical Research, Inc. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 766,666 +24.1%
Value US$11,499,990
KERINS PATRICK J Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
MOTT DAVID M Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
BASKETT FOREST Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 133,333 +4.2%
Value US$1,999,995
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-11 2023-08-01 S Sale
ROSS ROBERT W.

Chief Executive Officer

Officer
37,721 -30.4%
486.78
US$4,655,205 		37,721 -30.4% 486.78 US$4,655,205
2023-08-11 2023-08-01 S Sale
Adams Chandra

Deputy GC

Officer
1,586 -27.5%
95.06
US$1,395,353 		1,586 -27.5% 95.06 US$1,395,353
2023-08-11 2023-08-01 S Sale
ONEILL ALISON

Chief Medical Officer

Officer
41,295 +18.2%
413.46
US$1,973,319 		41,295 +18.2% 413.46 US$1,973,319
2023-08-11 2023-08-01 S Sale
FEES JESSICA

Chief Financial Officer

Officer
9,434 -8.5%
0.94
US$8,868 		9,434 -8.5% 0.94 US$8,868
2022-08-05 2022-08-03 S Sale
Palombella Vito J.

Chief Scientific Officer

Officer
4,463 -4.9%
1.72
US$7,676 		4,463 -4.9% 1.72 US$7,676
2022-08-05 2022-08-03 S Sale
FEES JESSICA

Chief Financial Officer

Officer
5,980 -5.1%
1.72
US$10,286 		5,980 -5.1% 1.72 US$10,286
2022-08-05 2022-08-03 S Sale
ONEILL ALISON

Chief Medical Officer

Officer
4,463 -6.5%
1.72
US$7,676 		4,463 -6.5% 1.72 US$7,676
2022-08-05 2022-08-03 S Sale
ROSS ROBERT W.

Chief Executive Officer

Officer
10,594 -9.6%
1.72
US$18,222 		10,594 -9.6% 1.72 US$18,222
2022-08-05 2022-08-03 S Sale
RATH HENRY C.

Chief Business Officer

Officer
5,676 -14.9%
1.72
US$9,763 		5,676 -14.9% 1.72 US$9,763
2022-01-14 2021-07-21 S Sale
ONEILL ALISON

Chief Medical Officer

Officer
14,809 -32.9%
6.10
US$90,335 		14,809 -32.9% 6.10 US$90,335
2022-01-14 2021-07-21 S Sale
Palombella Vito J.

Chief Scientific Officer

Officer
26,325 -32.9%
6.10
US$160,582 		26,325 -32.9% 6.10 US$160,582
2022-01-14 2021-07-21 S Sale
ROSS ROBERT W.

Chief Executive Officer

Officer
33,500 -38.1%
6.10
US$204,350 		33,500 -38.1% 6.10 US$204,350
2022-01-14 2021-07-21 S Sale
3.0
Goater Jeff
Non-Executive Director
127,778 -49.7%
6.10
US$779,446 		127,778 -49.7% 6.10 US$779,446
2022-01-14 2021-07-21 S Sale
FEES JESSICA

Chief Financial Officer

Officer
19,854 -20.0%
6.10
US$121,109 		19,854 -20.0% 6.10 US$121,109
2022-01-14 2021-07-21 S Sale
Nogelo Liisa I

Chief Legal Officer

Officer
26,325 -32.9%
6.10
US$160,582 		26,325 -32.9% 6.10 US$160,582
2021-06-11 2021-06-11 S Sale
3.0
Goater Jeff
Non-Executive Director
15,273 -5.6%
7.61
US$116,226 		15,273 -5.6% 7.61 US$116,226
2021-06-11 2021-06-10 S Sale
3.0
Goater Jeff
Non-Executive Director
234,727 -47.3%
7.66
US$1,798,619 		234,727 -47.3% 7.66 US$1,798,619
2021-02-18 2021-02-16 PlS Planned sale
ROSS ROBERT W.

Chief Medical Officer

Officer
1,000 -1.1%
11.35
US$11,350 		1,000 -1.1% 11.35 US$11,350
2021-02-09 2021-02-08 PlS Planned sale
3.0
Goater Jeff

Chief Executive Officer

Executive Director
2,500 -0.9%
12.50
US$31,250 		2,500 -0.9% 12.50 US$31,250
2021-02-09 2021-02-08 PlS Planned sale
FEES JESSICA

See Remarks

Officer
1,500 -1.5%
12.45
US$18,675 		1,500 -1.5% 12.45 US$18,675
2021-02-03 2021-02-01 PlS Planned sale
3.0
Goater Jeff

Chief Executive Officer

Executive Director
2,500 -0.9%
10.69
US$26,718 		2,500 -0.9% 10.69 US$26,718
2021-02-03 2021-02-01 PlS Planned sale
FEES JESSICA

See Remarks

Officer
1,500 -1.5%
11.19
US$16,785 		1,500 -1.5% 11.19 US$16,785
2021-01-21 2021-01-19 PlS Planned sale
3.0
Goater Jeff

Chief Executive Officer

Executive Director
5,000 -1.9%
13.00
US$65,000 		5,000 -1.9% 13.00 US$65,000
2021-01-15 2021-01-15 PlS Planned sale
ROSS ROBERT W.

Chief Medical Officer

Officer
2,000 -2.2%
12.25
US$24,500 		2,000 -2.2% 12.25 US$24,500
2021-01-15 2021-01-14 PlS Planned sale
ROSS ROBERT W.

Chief Medical Officer

Officer
7,000 -7.1%
11.95
US$83,650 		7,000 -7.1% 11.95 US$83,650
2020-12-21 2020-12-17 S Sale
3.4
GRAYZEL DAVID S.
Non-Executive Director
1,700,000 -36.6%
18.10
US$30,770,000 		1,700,000 -36.6% 18.10 US$30,770,000
2020-12-21 2020-12-17 S Sale
Atlas Venture Fund IX, L.P.
Large shareholder
1,700,000 -36.6%
18.10
US$30,770,000 		1,700,000 -36.6% 18.10 US$30,770,000
2020-12-17 2020-12-15 PlS Planned sale
ROSS ROBERT W.

Chief Medical Officer

Officer
1,000 -1.0%
10.48
US$10,480 		1,000 -1.0% 10.48 US$10,480
2020-12-15 2020-12-11 PlS Planned sale
ROSS ROBERT W.

Chief Medical Officer

Officer
1,405 -1.4%
10.05
US$14,120 		1,405 -1.4% 10.05 US$14,120
2020-11-13 2020-11-11 PlS Planned sale
ROSS ROBERT W.

Chief Medical Officer

Officer
595 -0.6%
10.05
US$5,980 		595 -0.6% 10.05 US$5,980
2020-10-16 2020-10-14 PlS Planned sale
ROSS ROBERT W.

Chief Medical Officer

Officer
4,000 -3.8%
10.05
US$40,200 		4,000 -3.8% 10.05 US$40,200
2020-09-03 2020-09-01 S Sale
3.1
EcoR1 Capital, LLC
Large shareholder
332,780 -6.6%
7.14
US$2,376,681 		332,780 -6.6% 7.14 US$2,376,681
2020-05-22 2020-05-20 S Sale
2.4
New Enterprise Associates 14, L.P.
Large shareholder
420,000 -12.7%
3.66
US$1,535,562 		420,000 -12.7% 3.66 US$1,535,562
2020-02-07 2020-02-05 B Purchase
3.0
Goater Jeff

Chief Executive Officer

Executive Director
5,000 +1.9%
3.23
US$16,150 		5,000 +1.9% 3.23 US$16,150
2018-04-23 2018-04-23 B Purchase Atlas Venture Fund IX, L.P. Large shareholder
100,000 +2.2%
15.00
US$1,500,000 		100,000 +2.2% 15.00 US$1,500,000
2018-04-23 2018-04-23 B Purchase Viswanathan Ravi Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase Sonsini Peter W. Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase Florence Anthony A. Jr. Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase GRAYZEL DAVID S. Non-Executive Director
100,000 +2.2%
15.00
US$1,500,000 		100,000 +2.2% 15.00 US$1,500,000
2018-04-23 2018-04-23 B Purchase New Enterprise Associates 14, L.P. Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase LV Management Group, LLC Large shareholder
266,000 +8.4%
15.00
US$3,990,000 		266,000 +8.4% 15.00 US$3,990,000
2018-04-23 2018-04-23 B Purchase Shanafelt Armen Non-Executive Director Large shareholder
266,000 +8.4%
15.00
US$3,990,000 		266,000 +8.4% 15.00 US$3,990,000
2018-04-23 2018-04-23 B Purchase BARRIS PETER J Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase BARRETT M JAMES Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase Novartis Institutes for BioMedical Research, Inc. Large shareholder
766,666 +24.1%
15.00
US$11,499,990 		766,666 +24.1% 15.00 US$11,499,990
2018-04-23 2018-04-23 B Purchase KERINS PATRICK J Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase SANDELL SCOTT D Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase MOTT DAVID M Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
2018-04-23 2018-04-23 B Purchase BASKETT FOREST Large shareholder
133,333 +4.2%
15.00
US$1,999,995 		133,333 +4.2% 15.00 US$1,999,995
Explore more

More insider trading research around Surface Oncology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America